WHO ending hydroxycholorquine trial for COVID
Berlin: The Globe Health Company states it’s ending a trial into whether anti-malaria drug hydroxychloroquine helps sufferers hospitalised with COVID-19. WHO stated Sat. it’s agreed the recommendation from that committee overseeing the trial to discontinue checking of hydroxychloroquine & lopinavir/ritonavir, a drug combination habituated to handle HIV/AIDS. The drugs have been being compared with standard …